StockData
HCW Biologics Inc. logo

HCW Biologics Inc. (HCWB) stock

HCWBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3095% below fair value
$0.76−0.01 (-1.65%)

Close on Nov 18, 2026Market cap $1.40MP/E –Yield –

HCW Biologics total assets

Total assets on the balance sheet at the end of each period.

HCW Biologics's total assets was $26.77M at Jun 30, 2026. For fiscal 2025 it was $24.52M, down 18.9% from the year before. The highest annual figure on record is $53.51M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$24.52M-18.9%
FY2024Dec 31, 2024$30.24M+6.0%
FY2023Dec 31, 2023$28.51M-39.1%
FY2022Dec 31, 2022$46.81M-12.5%
FY2021Dec 31, 2021$53.51M+247.5%
FY2020Dec 31, 2020$15.40M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$26.77M-7.4%
Q1 FY2026Mar 31, 2026$27.34M+4.0%
Q4 FY2025Dec 31, 2025$24.52M-18.9%
Q3 FY2025Sep 30, 2025$25.45M-4.2%
Q2 FY2025Jun 30, 2025$28.91M+7.8%
Q1 FY2025Mar 31, 2025$26.29M-13.6%
Q4 FY2024Dec 31, 2024$30.24M+6.0%
Q3 FY2024Sep 30, 2024$26.56M-25.4%
Q2 FY2024Jun 30, 2024$26.82M-32.1%
Q1 FY2024Mar 31, 2024$30.43M-30.1%
Q4 FY2023Dec 31, 2023$28.51M-39.1%
Q3 FY2023Sep 30, 2023$35.62M-30.6%
Q2 FY2023Jun 30, 2023$39.48M-16.7%
Q1 FY2023Mar 31, 2023$43.53M-14.6%
Q4 FY2022Dec 31, 2022$46.81M-12.5%
Q3 FY2022Sep 30, 2022$51.35M-9.0%
Q2 FY2022Jun 30, 2022$47.41M+263.7%
Q1 FY2022Mar 31, 2022$50.96M+230.9%
Q4 FY2021Dec 31, 2021$53.51M–
Q3 FY2021Sep 30, 2021$56.41M–
Q2 FY2021Jun 30, 2021$13.03M–
Q4 FY2020Dec 31, 2020$15.40M–

More HCW Biologics figures

See a number that looks wrong?